Previous 10 | Next 10 |
2024-02-23 06:53:00 ET How to Identify Trends With Penny Stocks to Profit in 2024 Identifying trends in penny stock trading is a pivotal strategy for investors aiming to profit in 2024. The journey to success involves deep research, leveraging technical analysis, and keeping a pulse on ...
2024-02-22 12:18:31 ET More on Novavax Novavax, Inc. (NVAX) CEO John Jacobs Presents at JPMorgan 42nd Annual Healthcare Conference Transcript J.P. Morgan 42nd Annual Healthcare Conference Novavax: Do Not Expect A Turnaround In 2024 Novavax settles COVID-19 va...
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024 PR Newswire GAITHERSBURG, Md. , Feb. 20, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advanc...
2024-02-15 05:17:00 ET After a brutal three-year period that saw its shares collapse by 99%, any remaining longtime shareholders of Novavax (NASDAQ: NVAX) are doubtlessly eager for the biotech to finally step out of the shadows of its first "success" and launch its next winner, even...
2024-02-14 11:43:00 ET More on BioNTech, Moderna, etc. Pfizer Stock: It's Time To Buy The Dip Pfizer Is A Great Investment Over The Next Decade; Buy Pfizer: The 6.3% Yield Is A Appealing Federal judge dismisses PhRMA challenge to Medicare price negotiations ...
2024-02-03 05:35:00 ET Everybody loves a good recovery story. You can get in on a promising company, with a potentially bright future ahead, but at a terrific price. And that means you could win big each time this player reports positive news and makes progress toward its goals. Of course, ...
2024-02-02 10:44:53 ET More on Novavax Novavax, Inc. (NVAX) CEO John Jacobs Presents at JPMorgan 42nd Annual Healthcare Conference Transcript J.P. Morgan 42nd Annual Healthcare Conference Novavax: Do Not Expect A Turnaround In 2024 Novavax to cut 12% of globa...
2024-01-31 10:17:51 ET More on Novavax Novavax, Inc. (NVAX) CEO John Jacobs Presents at JPMorgan 42nd Annual Healthcare Conference Transcript J.P. Morgan 42nd Annual Healthcare Conference Novavax: Do Not Expect A Turnaround In 2024 Masking returns to some U.S...
2024-01-31 00:21:00 ET Summary Q4 marks the end of a difficult year for Russell 2000 earnings. Energy is no longer the 'top dog' from an earnings growth contribution perspective. Financials has the largest earnings weight for the second consecutive quarter. By Taji...
2024-01-29 08:15:00 ET Like many of the biotechs pursuing coronavirus vaccine development, Novavax (NASDAQ: NVAX) has seen better days. Its shares are down by 96% over the past three years, and the company's remaining shareholders face fading hopes for a spontaneous revival. Non...
News, Short Squeeze, Breakout and More Instantly...
Shares of Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) fell sharply during Friday's session after the company reduced its dividend and...
2024-05-17 05:40:00 ET Novavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their shares soared -- in fact, Novavax rose the most, gaining 2,700% in 2020 compared to a 400% increase for ...
2024-05-16 09:15:00 ET If you'd invested $10,000 in Novavax (NASDAQ: NVAX) a year ago, you would have made a risky bet. That's because the biotech company had issued a going concern earlier this year. This warning meant that, if uncertainty persisted, the company might have had to s...